Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
16.08
-1.02
(-5.95%)
At close: March 5 at 4:00:00 PM EST
16.00
-0.08
(-0.51%)
After hours: March 5 at 6:41:00 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-3,581.40
-1,180.87
-1,257.10
-1,586.72
Investing Cash Flow
-258.55
-311.17
-87.21
-312.25
Financing Cash Flow
3,599.33
1,000
1,355.07
2,312.42
End Cash Position
233.94
66.53
558.57
547.81
Income Tax Paid Supplemental Data
105.83
63.56
--
--
Capital Expenditure
-295.79
-288.71
-185.98
-422.59
Issuance of Capital Stock
--
--
1,355.07
2,312.42
Free Cash Flow
-3,877.19
-1,469.58
-1,443.08
-2,009.31
12/31/2021 - 11/13/2024
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
CUE Cue Biopharma, Inc.
1.1200
-4.27%
CHOSA.ST CHOSA Oncology AB
0.7540
-0.79%
ASCLF Ascletis Pharma Inc.
0.8388
0.00%
CRTX.L CRISM Therapeutics Corporation
6.50
0.00%
PLRZ Polyrizon Ltd.
0.7704
+7.10%
RGBP Regen BioPharma, Inc.
0.0550
0.00%
JUNS Jupiter Neurosciences, Inc.
0.6420
+5.30%
SEPN Septerna, Inc.
5.93
-3.73%
INTS Intensity Therapeutics, Inc.
2.3200
+4.98%
SER Serina Therapeutics, Inc.
4.6900
-1.47%